Table of Contents

1 Report Overview

• 1.1 Study Scope
• 1.2 Key Market Segments
• 1.3 Players Covered
• 1.4 Market Analysis by Type
  • 1.4.1 Global Antibody Humanization Market Size Growth Rate by Type (2014-2025)
  • 1.4.2 Monoclonal Antibodies
  • 1.4.3 Bispecific Antibodies
  • 1.4.4 CDR Grafted Antibodies
• 1.5 Market by Application
  • 1.5.1 Global Antibody Humanization Market Share by Application (2014-2025)
  • 1.5.2 HIV
  • 1.5.3 SARS
  • 1.5.4 RSV
  • 1.5.5 Prion
• 1.6 Study Objectives
• 1.7 Years Considered

2 Global Growth Trends

• 2.1 Antibody Humanization Market Size
• 2.2 Antibody Humanization Growth Trends by Regions
  • 2.2.1 Antibody Humanization Market Size by Regions (2014-2025)
  • 2.2.2 Antibody Humanization Market Share by Regions (2014-2019)
• 2.3 Industry Trends
  • 2.3.1 Market Top Trends
  • 2.3.2 Market Drivers
  • 2.3.3 Market Opportunities

3 Market Share by Key Players

• 3.1 Antibody Humanization Market Size by Manufacturers
  • 3.1.1 Global Antibody Humanization Revenue by Manufacturers (2014-2019)
  • 3.1.2 Global Antibody Humanization Revenue Market Share by Manufacturers (2014-2019)
  • 3.1.3 Global Antibody Humanization Market Concentration Ratio (CR5 and HHI)
• 3.2 Antibody Humanization Key Players Head office and Area Served
• 3.3 Key Players Antibody Humanization Product/Solution/Service
• 3.4 Date of Enter into Antibody Humanization Market
• 3.5 Mergers & Acquisitions, Expansion Plans

4 Breakdown Data by Type and Application

• 4.1 Global Antibody Humanization Market Size by Type (2014-2019)
• 4.2 Global Antibody Humanization Market Size by Application (2014-2019)

5 United States

• 5.1 United States Antibody Humanization Market Size (2014-2019)
• 5.2 Antibody Humanization Key Players in United States
• 5.3 United States Antibody Humanization Market Size by Type
• 5.4 United States Antibody Humanization Market Size by Application

6 Europe

• 6.1 Europe Antibody Humanization Market Size (2014-2019)
• 6.2 Antibody Humanization Key Players in Europe
• 6.3 Europe Antibody Humanization Market Size by Type
• 6.4 Europe Antibody Humanization Market Size by Application

7 China

• 7.1 China Antibody Humanization Market Size (2014-2019)
• 7.2 Antibody Humanization Key Players in China
• 7.3 China Antibody Humanization Market Size by Type
• 7.4 China Antibody Humanization Market Size by Application

8 Japan

• 8.1 Japan Antibody Humanization Market Size (2014-2019)
• 8.2 Antibody Humanization Key Players in Japan
• 8.3 Japan Antibody Humanization Market Size by Type
• 8.4 Japan Antibody Humanization Market Size by Application

9 Southeast Asia

• 9.1 Southeast Asia Antibody Humanization Market Size (2014-2019)
• 9.2 Antibody Humanization Key Players in Southeast Asia
• 9.3 Southeast Asia Antibody Humanization Market Size by Type
• 9.4 Southeast Asia Antibody Humanization Market Size by Application

10 India

• 10.1 India Antibody Humanization Market Size (2014-2019)
• 10.2 Antibody Humanization Key Players in India
• 10.3 India Antibody Humanization Market Size by Type
• 10.4 India Antibody Humanization Market Size by Application

11 Central & South America

• 11.1 Central & South America Antibody Humanization Market Size (2014-2019)
• 11.2 Antibody Humanization Key Players in Central & South America
• 11.3 Central & South America Antibody Humanization Market Size by Type
• 11.4 Central & South America Antibody Humanization Market Size by Application

12 International Players Profiles

• 12.1 Accurus Biosciences
  • 12.1.1 Accurus Biosciences Company Details
  • 12.1.2 Company Description and Business Overview
  • 12.1.3 Antibody Humanization Introduction
  • 12.1.4 Accurus Biosciences Revenue in Antibody Humanization Business (2014-2019)
  • 12.1.5 Accurus Biosciences Recent Development
• 12.2 IONTAS
  • 12.2.1 IONTAS Company Details
  • 12.2.2 Company Description and Business Overview
  • 12.2.3 Antibody Humanization Introduction
  • 12.2.4 IONTAS Revenue in Antibody Humanization Business (2014-2019)
  • 12.2.5 IONTAS Recent Development
• 12.3 Lonza
  • 12.3.1 Lonza Company Details
  • 12.3.2 Company Description and Business Overview
  • 12.3.3 Antibody Humanization Introduction
  • 12.3.4 Lonza Revenue in Antibody Humanization Business (2014-2019)
  • 12.3.5 Lonza Recent Development
• 12.4 Oak BioSciences
  • 12.4.1 Oak BioSciences Company Details
  • 12.4.2 Company Description and Business Overview
  • 12.4.3 Antibody Humanization Introduction
  • 12.4.4 Oak BioSciences Revenue in Antibody Humanization Business (2014-2019)
  • 12.4.5 Oak BioSciences Recent Development
• 12.5 Panorama Research
  • 12.5.1 Panorama Research Company Details
  • 12.5.2 Company Description and Business Overview
  • 12.5.3 Antibody Humanization Introduction
  • 12.5.4 Panorama Research Revenue in Antibody Humanization Business (2014-2019)
  • 12.5.5 Panorama Research Recent Development
• 12.6 PX'Therapeutics
  • 12.6.1 PX'Therapeutics Company Details
  • 12.6.2 Company Description and Business Overview
  • 12.6.3 Antibody Humanization Introduction
  • 12.6.4 PX'Therapeutics Revenue in Antibody Humanization Business (2014-2019)
  • 12.6.5 PX'Therapeutics Recent Development
• 12.7 Yurogen Biosystems
  • 12.7.1 Yurogen Biosystems Company Details
  • 12.7.2 Company Description and Business Overview
  • 12.7.3 Antibody Humanization Introduction
  • 12.7.4 Yurogen Biosystems Revenue in Antibody Humanization Business (2014-2019)
  • 12.7.5 Yurogen Biosystems Recent Development

13 Market Forecast 2019-2025

• 13.1 Market Size Forecast by Regions
• 13.2 United States
• 13.3 Europe
• 13.4 China
• 13.5 Japan
• 13.6 Southeast Asia
• 13.7 India
• 13.8 Central & South America
• 13.9 Market Size Forecast by Product (2019-2025)
• 13.10 Market Size Forecast by Application (2019-2025)

14 Analyst's Viewpoints/Conclusions

15 Appendix

• 15.1 Research Methodology
  • 15.1.1 Methodology/Research Approach
    • 15.1.1.1 Research Programs/Design
    • 15.1.1.2 Market Size Estimation
    • 12.1.1.3 Market Breakdown and Data Triangulation
  • 15.1.2 Data Source
    • 15.1.2.1 Secondary Sources
    • 15.1.2.2 Primary Sources
• 15.2 Disclaimer

In 2018, the global Antibody Humanization market size was million US$ and it is expected to reach million US$ by the end of 2025, with a CAGR of during 2019-2025.

This report focuses on the global Antibody Humanization status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Antibody Humanization development in United States, Europe and China.

The key players covered in this study
Accurus Biosciences
IONTAS
Lonza
Oak BioSciences
Panorama Research
PX'Therapeutics
Yurogen Biosystems
...

Market segment by Type, the product can be split into
Monoclonal Antibodies
Bispecific Antibodies
CDR Grafted Antibodies

Market segment by Application, split into
HIV
SARS
RSV
Prion

Market segment by Regions/Countries, this report covers
United States
Europe
China
Japan
Southeast Asia
India
Central & South America

The study objectives of this report are:
To analyze global Antibody Humanization status, future forecast, growth opportunity, key market and key players.
To present the Antibody Humanization development in United States, Europe and China.
To strategically profile the key players and comprehensively analyze their development plan and strategies.
To define, describe and forecast the market by product type, market and key regions.

In this study, the years considered to estimate the market size of Antibody Humanization are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025
For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.